Milrinone (DrugBank: Milrinone)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
294 | 先天性横隔膜ヘルニア | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02951130 (ClinicalTrials.gov) | August 22, 2017 | 14/10/2016 | Milrinone in Congenital Diaphragmatic Hernia | Milrinone in Congenital Diaphragmatic Hernia | Congenital Diaphragmatic Hernia;Persistent Pulmonary Hypertension of the Newborn;Hypoxemic Respiratory Failure;Pulmonary Hypoplasia | Drug: Milrinone;Drug: Placebo (5% Dextrose) | NICHD Neonatal Research Network | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Recruiting | N/A | 168 Hours | All | 66 | Phase 2 | United States |